048530.KQ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 02:30):

iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs...

Stats
Today's Volume	71 608.00
Average Volume	242 091
Market Cap	226.70B
EPS	KRW0 ( 2024-02-14 )
Next earnings date	( KRW0 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW9.15 (0.13%)

Volume Correlation

Long: 0.09 (neutral)

Short: -0.98 (very strong negative)

Signal:(50.262) Neutral

iNtRON Biotechnology, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

iNtRON Biotechnology, Correlation - Currency/Commodity

0.29
( neutral )

0.21
( neutral )

0.38
( neutral )

0.32
( neutral )

-0.07
( neutral )

-0.49
( neutral )

iNtRON Biotechnology, Financials

Annual	2023
Revenue:	KRW9.59B
Gross Profit:	KRW4.56B (47.58 %)
EPS:	KRW-292.11

Q4	2023
Revenue:	KRW3.72B
Gross Profit:	KRW2.30B (61.95 %)
EPS:	KRW-111.56

Q3	2023
Revenue:	KRW1.67B
Gross Profit:	KRW444.86M (26.62 %)
EPS:	KRW-78.09

Q2	2023
Revenue:	KRW2.12B
Gross Profit:	KRW934.27M (44.03 %)
EPS:	KRW-55.66

Financial Reports:

No articles found.

iNtRON Biotechnology,

iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.